Abstract
The aim of the study was to find out whether low phospholamban level in atria as compared with ventricles is associated with differences in sarcoplasmic reticular Ca2+-uptake and contractile performance. Relationship between phospholamban and β-adrenergic stimulation in rat left atria and papillary muscles were examined by means of contractile measurements, sarcoplasmic reticular oxalate-supported Ca2+-uptake, and Western blotting of phosphorylated phospholamban. Phosphoprotein determination after β-adrenergic stimulation demonstrated that the levels of Ser16 and Thr17 phosphorylated phospholamban in atria remained at about one-third of that in ventricles. However, comparison of sarcoplasmic reticular Ca2+-uptake in control and isoproterenol perfused preparations demonstrated that the effect of β-adrenergic stimulation on sarcoplasmic reticular Ca2+-uptake was stronger in atrial preparations. Moreover, atria responded to isoproterenol with much larger increases in developed tension, contractility and relaxation rates than papillary muscles. Thus, despite lower level of phospholamban, the β-adrenergic activation of sarcoplasmic reticular Ca2+-uptake and contractile indices are higher in atria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agata N, Tanaka H, Shigenobu K: Inotropic effects of ryanodine and nicardipine on fetal, neonatal and adult guinea-pig myocardium. Eur J Pharmacol 260: 47–55, 1994
Asgrimsson H, Johannsson M, Arnardottir SA: Excitation and contraction in atrial and ventricular myocardium of the guinea-pig. Acta Physiol Scand 153: 133–141, 1995
Korecky B, Michael LH: Regional differences in contraction of mammalian hearts. Adv Stud Card Struct Metab 4: 77–78, 1974
Samuel J-L, Rappaport L, Syrovy I, Wisnewsky C, Marotte F, Whalen RG, Schwartz K: Differential effect of thyroxine on atrial and ventricular isomyosins in rats. Am J Physiol 250: H333–H341, 1986
Minajeva A, Kaasik A, Paju K, Seppet E, Lompre A-M, Veksler V, Ventura-Clapier R: Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart. Am J Physiol 273: H2498–H2507, 1997
Kadambi VJ, Koss KL, Grupp IL, Kranias EG: Phospholamban modulates murine atrial contractile parameters and responses to β-adrenergic agonists. J Mol Cell Cardiol 30: 1275–1284, 1998
Koss KL, Ponniah S, Jones WK, Grupp IL, Kranias EG: Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses. Circ Res 77: 342–353, 1995
Koss KL, Grupp IL, Kranias EG: The relative phospholamban and SERCA2 ratio: A critical determinant of myocardial contractility. Basic Res Cardiol 92 (suppl 1): 17–24, 1997
Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG: Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-stimulation. Circ Res 1994; 75: 401–409
Kaasik A, Seppet EK, Ohisalo JJ: Enhanced negative inotropic effect of an adenosine A1-receptor agonist in rat left atria in hypothyroidism. J Mol Cell Cardiol 26: 509–517, 1994
Kaasik A, Paju K, Vetter R, Seppet EK: Thyroid hormones increase the contractility but suppress the effects of β-adrenergic agonist by decreasing the phospholamban expression in rat atria. Cardiovasc Res 35: 106–112, 1997
Lowry OH, Rosebrough NJ, Far AL, Randall RJ: Protein measurement with the Folin reagent. J Biol Chem 193: 265–275, 1951
Drago GA, Colyer J: Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. J Biol Chem 269: 25073–25077, 1994
Ross J Jr, Miura T, Kambayashi M, Eising GP, Ryu KH: Adrenergic control of the force-frequency relation. Circulation 92: 2327–2332, 1995
Freestone NS, Ribaric S, Scheuermann M, Mauser U, Paul M, Vetter R: Differential lusitropic responsiveness to β-adrenergic stimulation in rat atrial and ventricular cardiac myocytes. Pflugers Arch 441: 78–87, 2000
Stemmer P, Akera T: Concealed positive force-frequency relationships in rat and mouse cardiac muscle revealed by ryanodine. Am J Physiol 251: H1106–H1110, 1986
Kaasik A, Minajeva A, Paju K, Eimre M, Seppet EK: Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles. Mol Cell Biochem 176: 119–126, 1997
Musser B, Morgan ME, Leid M, Murray TF, Linden J, Vestal RE: Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol. 246: 105–111, 1993
Haghighi K, Kadambi VJ, Koss KL, Luo W, Harrer JM, Ponniah S, Zhou Z, Kranias EG: In vitro and in vivo promoter analyses of the mouse phospholamban gene. Gene 203: 199–207, 1997
Mearow KM, Thilander BG, Khan I, Garfield RE, Grover A: In situ hybridization and immunocytochemical localization of SERCA2 encoded Ca2+ pump in rabbit heart and stomach. Mol Cell Biochem 121: 155–165, 1993
Kimura Y, Kurzydlowski K, Tada M, MacLennan DH: Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 272: 15061–15064, 1997
Kiss E, Jakab G, Kranias E, Edes I: Thyroid hormones-induced alterations in phospholamban protein expression. Regulatory effects of sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res 75: 245–251, 1994
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaasik, A., Paju, K., Minajeva, A. et al. Decreased expression of phospholamban is not associated with lower β-adrenergic activation in rat atria. Mol Cell Biochem 223, 109–115 (2001). https://doi.org/10.1023/A:1017945810355
Issue Date:
DOI: https://doi.org/10.1023/A:1017945810355